12th Jul 2022 7:00 am |
RNS |
Grant of Options |
8th Jul 2022 5:16 pm |
RNS |
Holding(s) in Company |
1st Jul 2022 7:00 am |
RNS |
Total Voting Rights |
30th Jun 2022 7:00 am |
RNS |
Result of AGM |
17th Jun 2022 2:51 pm |
RNS |
Holdings in Company |
6th Jun 2022 7:00 am |
RNS |
Publication of Annual Report |
27th May 2022 7:00 am |
RNS |
Notice of AGM |
16th May 2022 7:00 am |
RNS |
Inducement Grants |
10th May 2022 7:00 am |
RNS |
Filing of Form 10-Q |
10th May 2022 7:00 am |
RNS |
MaxCyte Reports First Quarter Financial Results |
4th May 2022 7:00 am |
RNS |
Upcoming Investor Conferences |
29th Apr 2022 2:41 pm |
RNS |
Total Voting Rights |
19th Apr 2022 7:00 am |
RNS |
Inducement Grants Under Nasdaq Listing Rule 5635 |
13th Apr 2022 7:00 am |
RNS |
Departure of CFO and Preliminary Q1 2022 Revenue |
11th Apr 2022 7:00 am |
RNS |
Holding(s) in Company |
1st Apr 2022 7:02 am |
RNS |
Total Voting Rights |
28th Mar 2022 1:19 pm |
RNS |
Grant of Options and PDMR Dealing |
28th Mar 2022 7:00 am |
RNS |
Grant of Options and PDMR Dealing |
23rd Mar 2022 7:00 am |
RNS |
Fourth Quarter and Full Year Financial Results |
10th Mar 2022 7:00 am |
RNS |
MaxCyte, Names Cenk Sumen Chief Scientific Officer |
8th Mar 2022 2:29 pm |
RNS |
Holding(s) in Company |
3rd Mar 2022 9:45 am |
RNS |
Holding(s) in Company |
1st Mar 2022 7:00 am |
RNS |
Block Listing Return |
24th Feb 2022 1:00 pm |
RNS |
Notice of Results |
22nd Feb 2022 3:56 pm |
RNS |
Holding(s) in Company |
21st Feb 2022 7:00 am |
RNS |
Consolidation of Trading Lines |
14th Feb 2022 1:00 pm |
RNS |
Upcoming Investor Conferences |
14th Feb 2022 7:00 am |
RNS |
Inducement Grants Under Nasdaq Listing Rule |
1st Feb 2022 7:00 am |
RNS |
License with Intima Bioscience |
24th Jan 2022 7:30 am |
RNS |
Preliminary Unaudited Q4 & FY 2021 Revenue Results |
29th Dec 2021 3:30 pm |
RNS |
Holdings in Company |
1st Dec 2021 5:00 pm |
RNS |
Total Voting Rights |
23rd Nov 2021 7:32 am |
RNS |
Purchase of Common Stock |
17th Nov 2021 5:36 pm |
RNS |
Exercise of options and PDMR Dealing |
11th Nov 2021 7:00 am |
RNS |
MaxCyte Reports Third Quarter Financial Results |
3rd Nov 2021 1:00 pm |
RNS |
Appointment of Chairman of the Board |
29th Oct 2021 5:01 pm |
RNS |
Result of AGM |
28th Oct 2021 3:00 pm |
RNS |
License with Nkarta, Inc. |
26th Oct 2021 7:00 am |
RNS |
Notice of Results |
6th Oct 2021 7:00 am |
RNS |
Holdings in Company |